Published Online
on May 26, 2008

A more recent version of this article appeared on July 1, 2008

This Article Full Text (PDF) Data Supplement All Versions of this Article: 52/1/30    most recent HYPERTENSIONAHA.108.114389v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Carter, B. L. Articles by Wright, J. T. Search for Related Content PubMed PubMed Citation Articles by Carter, B. L. Articles by Wright, J. T., Jr Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information High Blood Pressure Hazardous Substances DB POTASSIUM Related Collections Cardiovascular Pharmacology Animal models of human disease Type 2 diabetes Glucose intolerance Clinical Studies

Submitted on April 3, 2008
Revised on April 19, 2008

Thiazide-Induced Dysglycemia. Call for Research From a Working Group From the National Heart, Lung, and Blood Institute

Barry L. Carter^*; Paula T. Einhorn; Michael Brands; Jiang He; Jeffrey A. Cutler; Paul K. Whelton; George L. Bakris; Frederick L. Brancati; William C. Cushman; Suzanne Oparil; and Jackson T. Wright Jr

From the Division of Clinical and Administrative Pharmacy (B.L.C.), College of Pharmacy and Department of Family Medicine, Roy J. and Lucille A. Carver College of Medicine, Iowa City, Iowa; Division of Prevention and Population Sciences (P.T.E., J.A.C.), National Heart, Lung, and Blood Institute, Bethesda, Md; Department of Physiology (M.B.), Medical College of Georgia, Augusta; Department of Epidemiology (J.H.), Tulane University School of Public Health and Tropical Medicine, New Orleans, La; Loyola University Medical Center (P.K.W.), Chicago, Ill; Hypertensive Diseases Unit (G.L.B.), University of Chicago, Ill; Departments of Medicine and Epidemiology (F.L.B.), Johns Hopkins University, Baltimore, Md; Memphis Veterans' Affairs Medical Center and Department of Preventive Medicine and Medicine (W.C.C.), University of Tennessee College of Medicine, Memphis; Division of Cardiovascular Diseases (S.O.), Department of Medicine, Physiology, and Biophysics, University of Alabama at Birmingham; and the Department of Medicine (J.T.W.), Case Western Reserve University, Cleveland, Ohio.

^* To whom correspondence should be addressed. E-mail: barry.carter{at}uiowa.edu.

This article has been cited by other articles:

				M. E. Ernst and M. Moser Use of Diuretics in Patients with Hypertension N. Engl. J. Med., November 26, 2009; 361(22): 2153 - 2164. [Full Text] [PDF]

				D. H. Ellison and J. Loffing Thiazide Effects and Adverse Effects: Insights From Molecular Genetics Hypertension, August 1, 2009; 54(2): 196 - 202. [Full Text] [PDF]

				R. M. Cooper-DeHoff, M. A. Pacanowski, and C. J. Pepine Cardiovascular therapies and associated glucose homeostasis: implications across the dysglycemia continuum. J. Am. Coll. Cardiol., February 3, 2009; 53(5 Suppl): S28 - S34. [Abstract] [Full Text] [PDF]

				T. Shafi, L. J. Appel, E. R. Miller III, M. J. Klag, and R. S. Parekh Changes in Serum Potassium Mediate Thiazide-Induced Diabetes Hypertension, December 1, 2008; 52(6): 1022 - 1029. [Abstract] [Full Text] [PDF]

				S. Dronavalli and G. L. Bakris Mechanistic Insights into Diuretic-Induced Insulin Resistance Hypertension, December 1, 2008; 52(6): 1009 - 1011. [Full Text] [PDF]

				R. Agarwal Hypertension, Hypokalemia, and Thiazide-Induced Diabetes: A 3-Way Connection Hypertension, December 1, 2008; 52(6): 1012 - 1013. [Full Text] [PDF]